Skip to content
Research Triangle Regional Partnership
  • Our Region
    • The Triangle
    • Our Counties
    • Talent
    • International
  • Do Business Here
    • Incentives & Grants
    • Investment
    • Startup Ecosystem
    • Featured Sites
  • Target Industries
    • Advanced Manufacturing
    • AgTech
    • CleanTech
      • EV & Battery Tech
    • Life Sciences
      • Gene & Cell Therapy
      • Bioeconomy
    • Technology
      • Cybersecurity
      • Defense Technology
      • Fintech
  • Newsroom
  • About Us
  • Events
  • Contact
  • Select Language
    • en_USEnglish
    • es_ESEspañol
    • fr_FRFrançais
    • de_DEDeutsch
    • it_ITItaliano
    • pl_PLPolski
    • sv_SESvenska
    • fiSuomi
    • da_DKDansk
    • he_ILעִבְרִית
    • zh_CNChinese
    • zh_TW繁體中文
    • ko_KR한국어
    • ja日本語

Life Sciences

NC State, biopharma company developing gene therapy for asthma

Date Published: February 6, 2020
NEW YORK, N.Y. —  Biopharmaceutical company Hoth Therapeutics has tapped NC State to collaborate and carry out a preclinical study…

As the world fights coronavirus, this Holly Springs plant is getting ready for the next pandemic

Date Published: February 4, 2020
While all the talk around the world is about the coronavirus, Seqirus, an Australian company, has quietly developed a new…
North Carolina Biotechnology Center name on a brick sign.

NC Biotech CEO Doug Edgeton: ‘We will lead science behind curative gene, cell therapies”

Date Published: January 31, 2020
RESEARCH TRIANGLE PARK — For the better part of four decades, North Carolina has steadily committed resources to developing biotechnologies…

bluebird bio launches gene therapy for severe blood disorder in Germany

Date Published: January 29, 2020
DURHAM — bluebird bio, a gene therapy company with operations in Durham, has launched for the first time its treatment…

A world first: Triangle’s Locus Biosciences to launch gene editing trial involving therapy ‘cocktail’

Date Published: January 10, 2020
Morrisville-based Locus Biosciences, a developer of precision antibacterial therapies, will conduct the world’s first clinical trial of a recombinant bacteriophage…

Duke researchers land $6M in federal grants to advance gene editing

Date Published: January 3, 2020
Hemophilia. Cystic fibrosis. Duchenne muscular dystrophy. Huntington’s disease. These are just a few of the thousands of disorders caused by…

Q2 Solutions plans $73M precision medicine lab, adding 750 jobs in Durham

Date Published: November 29, 2019
Q2 Solutions, a Morrisville clinical trial laboratory services provider, announced plans today for a new $73 million precision medicine facility…

RTP gene tech firm lands deal worth up to $90M for 8 nervous system therapies

Date Published: November 14, 2019
By Rick Smith, WRAL TechWire RESEARCH TRIANGLE PARK – StrideBio, a life science startup focused on gene editing technology, has…

Novo Nordisk invests in new $40M wastewater plant, turns over to Clayton to help spur BioPharma Crescent growth

Date Published: October 15, 2019
CLAYTON – A public-private partnership has cut the ribbon for a regional industrial wastewater pretreatment facility in Clayton worth $40…

Contact Us

Send us an email to learn more about the Research Triangle Region.

Ryan Combs Executive Director, Research Triangle Regional Partnership Email rcombs@researchtriangle.org Email Research Triangle, North Carolina
A Special Thank You To Our Corporate Partners
Delta
Official Airline of the RTRP
Duke Energy
©2025 Research Triangle Regional Partnership
  • LinkedIn
  • YouTube
  • Accessibility
  • Privacy Policy
  • Sitemap